Expanding Translational Research in Arkansas
扩大阿肯色州的转化研究
基本信息
- 批准号:10443806
- 负责人:
- 金额:$ 426.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAfrican AmericanAreaArkansasCardiovascular DiseasesClinical ResearchClinical and Translational Science AwardsCollaborationsCommunitiesComplexDeath RateDiabetes MellitusEcosystemEnvironmentFacultyFosteringFoundationsFutureGrowthHealthHealth BenefitHealthcareHealthcare SystemsHomeIndividualInformaticsInstitutionInterdisciplinary StudyInterventionKnowledgeLeadLinkLongevityMeasurableMedicalMethodsMinority GroupsMissionObesityPediatric HospitalsPopulationPositioning AttributePovertyProcessResearchResearch InstituteResearch MethodologyResearch PersonnelResearch SupportResearch TrainingResistanceResourcesRewardsRural MinorityRural PopulationScienceSiteTrainingTranslational ResearchUnderrepresented PopulationsUniversitiesVeteransVisionWorkbasecareercareer developmentcommunity engagementhealth care disparityimprovedinnovationmetropolitannovel strategiesprogramsrural areasuccesstranslational scientist
项目摘要
Contact PD/PI: James, Laura P
PROJECT SUMMARY
Overall
The health challenges of Arkansas mandate that the University of Arkansas for Medical Sciences (UAMS)
Translational Research Institute (TRI) works in partnership with communities and stakeholders to develop and
conduct clinical and translational research (CTR) that will measurably improve the health of Arkansans. As the
academic home for translational researchers, our Clinical and Translational Science Award (CTSA) hub has
developed efficient and resourceful workflows, established excellent research training and educational
programs, and launched initiatives to support the growth of team science and community engagement. With
maturation of our hub, we have expanded our integration with our participating sites, Arkansas Children’s
Hospital (ACH) and the Central Arkansas Veteran’s Healthcare System (CAVHS), which provides us with
diverse perspectives and a collaborative foundation of multidisciplinary research across these three closely-
linked institutions. Collectively, hub faculty from UAMS, ACH, and CAVHS have rich expertise in CTR
engaging rural and underrepresented populations and will help us expand CTR resources more broadly. Our
vision is to be a thriving translational research ecosystem that catalyzes discoveries into health solutions for
rural and underrepresented populations. Our future work, based on our previous accomplishments, will be
guided by the following five specific aims: Aim 1). Enrich our environment for CTR by supporting and rewarding
team-based collaborations at the local and national level; Aim 2). Enhance training to researchers across the
translational research spectrum and at all career levels through innovative and team-based approaches; Aim
3). Increase partnerships with diverse stakeholders to expand the impact of clinical and translational research
in and with rural populations; Aim 4). Streamline translational research processes and enhance research
quality with state-of-the-art informatics approaches and methods; and Aim 5). Expand clinical and translational
research opportunities across the lifespan and in underrepresented populations. The collective impact of our
success as a CTSA hub will provide “real world solutions” for effective CTR in rural and underrepresented
populations, a facet insufficiently represented within the CTSA Consortium.
Page 303
Project Summary/Abstract
Contact PD/PI: James, Laura P
联系PD/PI:James,Laura P
项目摘要
全面的
阿肯色州的健康挑战要求阿肯色大学医学科学(UAMS)
转化研究所(TRI)与社区和利益相关者合作发展和
进行临床和翻译研究(CTR),可以衡量地改善阿肯色州的健康状况。作为
翻译研究人员的学术主场,我们的临床和转化科学奖(CTSA)中心已有
开发了高效且足智多谋的工作流程,建立了出色的研究培训和教育
计划,并发起了支持团队科学和社区参与的成长的举措。和
枢纽的成熟,我们扩大了与参与网站的集成,阿肯色州儿童
医院(ACH)和阿肯色州中央资深医疗保健系统(CAVHS),它为我们提供了
潜水员的观点和这三个近距离研究的多学科研究的合作基础
链接的机构。总体而言,UAMS,ACH和CAVH的枢纽教师在CTR方面拥有丰富的专业知识
参与粗糙和代表性不足的人群,将有助于我们更广泛地扩展CTR资源。我们的
愿景将成为一个蓬勃发展的转化研究生态系统,将发现催化为健康解决方案
粗糙且代表性不足的人群。我们的未来工作,基于我们以前的成就,将是
在以下五个特定目标的指导下:目标1)。通过支持和奖励的CTR环境
基于团队的地方和国家一级的合作;目标2)。增强对整个研究人员的培训
通过创新和基于团队的方法,转化研究范围以及所有职业水平;目的
3)。增加与潜水员利益相关者的伙伴关系,以扩大临床和翻译研究的影响
在大量的人口中;目标4)。简化翻译研究过程并增强研究
具有最先进的信息方法和方法的质量;和目标5)。扩展临床和翻译
整个生命周期和代表性不足的人群的研究机会。我们的集体影响
作为CTSA枢纽的成功将提供“现实世界的解决方案”,以使其在粗糙和代表性不足的情况下有效CTR
种群是CTSA财团内代表不足的方面。
第303页
项目摘要/摘要
联系PD/PI:James,Laura P
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura P James其他文献
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations.
免提分析尿液检测技术经过验证可用于毒品犯罪调查。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:4.1
- 作者:
Marina Avram;Carter Bodinger;Madeline A Clark;Daniel G Stuckey;Samuel E Mathews;Susan N Stogsdill;Elyse C Barna;David K Williams;Mitchell R. McGill;W. Fantegrossi;Erica L Liebelt;Laura P James;G. Endres;Jeffery H Moran - 通讯作者:
Jeffery H Moran
Laura P James的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura P James', 18)}}的其他基金
CTSA Admin Supp2 Maternal Mortality - UL1 - Revision
CTSA Admin Supp2 孕产妇死亡率 - UL1 - 修订版
- 批准号:
10200507 - 财政年份:2020
- 资助金额:
$ 426.9万 - 项目类别:
CTSA Admin Supp QAQC - UL1 - Revision
CTSA 管理补充 QAQC - UL1 - 修订版
- 批准号:
10158964 - 财政年份:2019
- 资助金额:
$ 426.9万 - 项目类别:
Arkansas ECHO ISPCTN Site (AREIS)
阿肯色州 ECHO ISPCTN 站点 (AREIS)
- 批准号:
10063720 - 财政年份:2016
- 资助金额:
$ 426.9万 - 项目类别:
Arkansas Center for Advancing Pediatric Therapeutics (ArCAPT)
阿肯色州儿科治疗促进中心 (ArCAPT)
- 批准号:
9262528 - 财政年份:2016
- 资助金额:
$ 426.9万 - 项目类别:
Dipstick Assay for Detection of Acetaminophen Protein Adducts
用于检测对乙酰氨基酚蛋白加合物的试纸测定
- 批准号:
8013387 - 财政年份:2010
- 资助金额:
$ 426.9万 - 项目类别:
Biomarkers of adverse responses to acetaminophen in children and adolescents
儿童和青少年对乙酰氨基酚不良反应的生物标志物
- 批准号:
8252206 - 财政年份:2009
- 资助金额:
$ 426.9万 - 项目类别:
Identification of new mechanistic biomarkers of adverse responses to acetaminophe
对乙酰氨基酚不良反应的新机制生物标志物的鉴定
- 批准号:
8063985 - 财政年份:2009
- 资助金额:
$ 426.9万 - 项目类别:
相似海外基金
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
- 批准号:
10558119 - 财政年份:2023
- 资助金额:
$ 426.9万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 426.9万 - 项目类别:
Identifying the Effects of Race-Related Stressors on Laboratory- Induced Stress and Craving among African Americans with Alcohol Use Disorder
确定种族相关压力源对患有酒精使用障碍的非裔美国人实验室诱发的压力和渴望的影响
- 批准号:
10664454 - 财政年份:2023
- 资助金额:
$ 426.9万 - 项目类别:
Enhancing Mentoring of Diverse Early Career Researchers
加强对多元化早期职业研究人员的指导
- 批准号:
10797836 - 财政年份:2023
- 资助金额:
$ 426.9万 - 项目类别:
Implementation and Implications of Sickle Cell Trait Screening in the NCAA
镰状细胞性状筛查在 NCAA 中的实施及其意义
- 批准号:
10842764 - 财政年份:2023
- 资助金额:
$ 426.9万 - 项目类别: